Please enable JavaScript to continue using this application.

Compare $BHVN vs $VIR | Chartloom

Compare

$BHVN vs $VIR

Biohaven Ltd · Vir Biotechnology Inc

BHVN

Biohaven Ltd

VIR

Vir Biotechnology Inc

Compare $BHVN vs $VIR

Comparing Biohaven Ltd and Vir Biotechnology Inc

BHVNBiohaven Ltd

VIRVir Biotechnology Inc

BHVNBiohaven Ltd

Market cap

$1.82B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

113.82x

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

-21.3%

FCF yield

-28.1%

VIRVir Biotechnology Inc

Market cap

$1.97B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

36.09x

Rev growth (TTM)

1496.1%

YTD performance

97.0%

52W performance

93.4%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BHVN

VIR

Detailed metrics comparison

BHVN

Biohaven Ltd

VIR

Vir Biotechnology Inc

Market Cap

BHVN$1.82B

VIR$1.97B

Enterprise Value

BHVN$1.84B

VIR$1.69B

Price

BHVN$12.08

VIR$11.70

P/E Ratio

BHVNN/A

VIRN/A

P/S Ratio

BHVN0.00x

VIR6.51x

EV/Sales

BHVN0.00x

VIR5.59x

EV/EBITDA

BHVN0.00x

VIR1.92x

P/B Ratio

BHVN159.05x

VIR1.92x

P/FCF Ratio

BHVNN/A

VIRN/A

EV/FCF

BHVN-3.60x

VIR-8.32x

PEG Ratio

BHVNN/A

VIRN/A

Forward P/E (NTM)

BHVNN/A

VIRN/A

Forward P/S (NTM)

BHVN113.82x

VIR36.09x

Revenue (TTM)

BHVN$0

VIR$303M

Revenue Growth (YoY)

BHVNN/A

VIR1496.1%

Forward Rev Growth

BHVN169.9%

VIR-58.9%

Gross Margin (TTM)

BHVN0.0%

VIR100.0%

Operating Margin (TTM)

BHVN0.0%

VIR0.0%

EBITDA Margin (TTM)

BHVN0.0%

VIR-45.9%

Net Margin (TTM)

BHVN0.0%

VIR-41.5%

FCF Margin (TTM)

BHVNN/A

VIR-67.1%

Net Income (TTM)

BHVN$-587M

VIR$-126M

FCF (TTM)

BHVN$-512M

VIR$-204M

EPS (TTM)

BHVN-$3.90

VIR-$0.75

ROE (TTM)

BHVN-63995.0%

VIR-1486.0%

ROA (TTM)

BHVN-13827.0%

VIR-1168.0%

ROIC (TTM)

BHVN-13277.0%

VIR-1486.0%

Cash

BHVN$238M

VIR$279M

Debt

BHVN$259M

VIR$0

Net Cash/Debt

BHVN$-21M

VIR$279M

Current Ratio (TTM)

BHVN4.73x

VIR6.04x

Quick Ratio (TTM)

BHVN4.30x

VIR5.69x

Debt/Equity (TTM)

BHVN21.23x

VIR0.00x

Debt/Assets (TTM)

BHVN0.0%

VIR0.0%

Interest Coverage (TTM)

BHVNN/A

VIRN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

VIR0.00x

Beta

BHVN3.18

VIR1.77

52W Performance

BHVN-21.3%

VIR93.4%

YTD Performance

BHVN11.4%

VIR97.0%

% from 52W High

BHVN-34.9%

VIR-2.6%

% from 52W Low

BHVN61.5%

VIR143.0%

Asset Turnover (TTM)

BHVN0.00x

VIR0.28x

FCF Yield (TTM)

BHVN-28.1%

VIR-10.3%

Earnings Yield (TTM)

BHVN-32.3%

VIR-6.4%

Dividend Yield (TTM)

BHVNN/A

VIRN/A

Rule of 40

BHVN0.0

VIR1,428.9

EV/GP/RG

BHVNN/A

VIRN/A

Ticker research

View BHVN research View VIR research

Metric	BHVN Biohaven Ltd	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$1.82B	$1.97B
Enterprise Value	$1.84B	$1.69B
Price	$12.08	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.51x
EV/Sales	0.00x	5.59x
EV/EBITDA	0.00x	1.92x
P/B Ratio	159.05x	1.92x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.60x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	113.82x	36.09x
Revenue & Growth
Revenue (TTM)	$0	$303M
Revenue Growth (YoY)	N/A	1496.1%
Forward Rev Growth	169.9%	-58.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-45.9%
Net Margin (TTM)	0.0%	-41.5%
FCF Margin (TTM)	N/A	-67.1%
Net Income (TTM)	$-587M	$-126M
FCF (TTM)	$-512M	$-204M
EPS (TTM)	-$3.90	-$0.75
ROE (TTM)	-63995.0%	-1486.0%
ROA (TTM)	-13827.0%	-1168.0%
ROIC (TTM)	-13277.0%	-1486.0%
Financial Health
Cash	$238M	$279M
Debt	$259M	$0
Net Cash/Debt	$-21M	$279M
Current Ratio (TTM)	4.73x	6.04x
Quick Ratio (TTM)	4.30x	5.69x
Debt/Equity (TTM)	21.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	1.77
52W Performance	-21.3%	93.4%
YTD Performance	11.4%	97.0%
% from 52W High	-34.9%	-2.6%
% from 52W Low	61.5%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-28.1%	-10.3%
Earnings Yield (TTM)	-32.3%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View VIR research

Valuation

P/S Ratio

BHVN

0.00x

VIR

6.51x

EV/FCF

VIR

-8.32x

BHVN

-3.60x

Growth & revenue

Revenue Growth TTM

VIR

1496.1%

Forward Revenue Growth

BHVN

169.9%

VIR

-58.9%

Profitability & performance

Gross Margin

VIR

100.0%

BHVN

0.0%

ROE

VIR

-1486.0%

BHVN

-63995.0%

FCF Yield %

VIR

-10.3%

BHVN

-28.1%

52-Week Performance

VIR

93.4%

BHVN

-21.3%

Detailed metrics comparison

BHVN

Biohaven Ltd

VIR

Vir Biotechnology Inc

Market Cap

BHVN$1.82B

VIR$1.97B

Enterprise Value

BHVN$1.84B

VIR$1.69B

Price

BHVN$12.08

VIR$11.70

P/E Ratio

BHVNN/A

VIRN/A

P/S Ratio

BHVN0.00x

VIR6.51x

EV/Sales

BHVN0.00x

VIR5.59x

EV/EBITDA

BHVN0.00x

VIR1.92x

P/B Ratio

BHVN159.05x

VIR1.92x

P/FCF Ratio

BHVNN/A

VIRN/A

EV/FCF

BHVN-3.60x

VIR-8.32x

PEG Ratio

BHVNN/A

VIRN/A

Forward P/E (NTM)

BHVNN/A

VIRN/A

Forward P/S (NTM)

BHVN113.82x

VIR36.09x

Revenue (TTM)

BHVN$0

VIR$303M

Revenue Growth (YoY)

BHVNN/A

VIR1496.1%

Forward Rev Growth

BHVN169.9%

VIR-58.9%

Gross Margin (TTM)

BHVN0.0%

VIR100.0%

Operating Margin (TTM)

BHVN0.0%

VIR0.0%

EBITDA Margin (TTM)

BHVN0.0%

VIR-45.9%

Net Margin (TTM)

BHVN0.0%

VIR-41.5%

FCF Margin (TTM)

BHVNN/A

VIR-67.1%

Net Income (TTM)

BHVN$-587M

VIR$-126M

FCF (TTM)

BHVN$-512M

VIR$-204M

EPS (TTM)

BHVN-$3.90

VIR-$0.75

ROE (TTM)

BHVN-63995.0%

VIR-1486.0%

ROA (TTM)

BHVN-13827.0%

VIR-1168.0%

ROIC (TTM)

BHVN-13277.0%

VIR-1486.0%

Cash

BHVN$238M

VIR$279M

Debt

BHVN$259M

VIR$0

Net Cash/Debt

BHVN$-21M

VIR$279M

Current Ratio (TTM)

BHVN4.73x

VIR6.04x

Quick Ratio (TTM)

BHVN4.30x

VIR5.69x

Debt/Equity (TTM)

BHVN21.23x

VIR0.00x

Debt/Assets (TTM)

BHVN0.0%

VIR0.0%

Interest Coverage (TTM)

BHVNN/A

VIRN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

VIR0.00x

Beta

BHVN3.18

VIR1.77

52W Performance

BHVN-21.3%

VIR93.4%

YTD Performance

BHVN11.4%

VIR97.0%

% from 52W High

BHVN-34.9%

VIR-2.6%

% from 52W Low

BHVN61.5%

VIR143.0%

Asset Turnover (TTM)

BHVN0.00x

VIR0.28x

FCF Yield (TTM)

BHVN-28.1%

VIR-10.3%

Earnings Yield (TTM)

BHVN-32.3%

VIR-6.4%

Dividend Yield (TTM)

BHVNN/A

VIRN/A

Rule of 40

BHVN0.0

VIR1,428.9

EV/GP/RG

BHVNN/A

VIRN/A

Ticker research

View BHVN research View VIR research

Metric	BHVN Biohaven Ltd	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$1.82B	$1.97B
Enterprise Value	$1.84B	$1.69B
Price	$12.08	$11.70
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.51x
EV/Sales	0.00x	5.59x
EV/EBITDA	0.00x	1.92x
P/B Ratio	159.05x	1.92x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.60x	-8.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	113.82x	36.09x
Revenue & Growth
Revenue (TTM)	$0	$303M
Revenue Growth (YoY)	N/A	1496.1%
Forward Rev Growth	169.9%	-58.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-45.9%
Net Margin (TTM)	0.0%	-41.5%
FCF Margin (TTM)	N/A	-67.1%
Net Income (TTM)	$-587M	$-126M
FCF (TTM)	$-512M	$-204M
EPS (TTM)	-$3.90	-$0.75
ROE (TTM)	-63995.0%	-1486.0%
ROA (TTM)	-13827.0%	-1168.0%
ROIC (TTM)	-13277.0%	-1486.0%
Financial Health
Cash	$238M	$279M
Debt	$259M	$0
Net Cash/Debt	$-21M	$279M
Current Ratio (TTM)	4.73x	6.04x
Quick Ratio (TTM)	4.30x	5.69x
Debt/Equity (TTM)	21.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	1.77
52W Performance	-21.3%	93.4%
YTD Performance	11.4%	97.0%
% from 52W High	-34.9%	-2.6%
% from 52W Low	61.5%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-28.1%	-10.3%
Earnings Yield (TTM)	-32.3%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1,428.9
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View VIR research